| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Chief Executive Officer
3 companies
Wong Roderick serves as a Chief Executive Officer at OBIO and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 25 buys and 0 sells. Those positions are worth an estimated $37.9M at current prices.
The biggest single holding is OBIO (~$28.1M) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 2,808,512 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2019 | IMVT Immunovant, Inc. | Chief Executive Officer | Buy | 46,999 | $10.40 | $488,960.24 | +20.5% | |
| Nov 19, 2019 | IMVT Immunovant, Inc. | Chief Executive Officer | Buy | 72,610 | $10.26 | $744,802.40 | +46.4% | |
| Nov 14, 2019 | IMVT Immunovant, Inc. | Chief Executive Officer | Buy | 126,000 | $10.17 | $1,281,420.00 | +413.1% | |
| Nov 11, 2019 | IMVT Immunovant, Inc. | Chief Executive Officer | Buy | 30,500 | $10.18 | $310,490.00 | New |